-
61
How do crime and neighborhood environment affect transit ridership? Evidence from five metropolitan cities in the Texas Triangle
Published 2025-01-01“…Using stop-level transit ridership and service characteristics data from transit agencies in five metropolitan areas in the Texas Triangle (Austin, Dallas, Fort Worth, Houston, and San Antonio) in 2018, we find that although the crime rate is negatively associated with ridership, better transit service characteristics such as higher service frequency and shorter average headway are associated with higher ridership, based on results of the negative binomial regression model. …”
Get full text
Article -
62
SSMM: Semi-supervised manifold method with spatial-spectral self-training and regularized metric constraints for hyperspectral image dimensionality reduction
Published 2025-02-01“…SSMM conducts various forms of experiments on the Houston 2013, Indian Pines, and Washington DC datasets. …”
Get full text
Article -
63
Complex cure kinetics of self-healing copolyester vitrimers via isothermal thermogravimetric analysis
Published 2025-02-01Get full text
Article -
64
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapy
Published 2024-02-01Get full text
Article -
65
-
66
-
67
-
68
-
69
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article -
70
-
71
-
72
-
73
Early tolerance and late persistence as alternative drug responses in cancer
Published 2025-02-01Get full text
Article -
74
-
75
-
76
Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab
Published 2025-02-01Get full text
Article -
77
-
78
Treatment efficacy for infantile epileptic spasms syndrome in children with trisomy 21
Published 2025-02-01Get full text
Article -
79
-
80